Comparison between Alpa Laboratories IPO and Central Bank of India IPO.
Alpa Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Central Bank of India IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Alpa Laboratories IPO is up to ₹61.07 Cr whereas the issue size of the Central Bank of India IPO is up to ₹816.00 Cr. The final issue price of Alpa Laboratories IPO is ₹68.00 per share and of Central Bank of India IPO is ₹102.00 per share.
| Alpa Laboratories IPO | Central Bank of India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹62.00 per share | ₹85.00 per share |
| Issue Price (Upper) | ₹68.00 per share | ₹102.00 per share |
| Issue Price (Final) | ₹68.00 per share | ₹102.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 100 shares | 60 shares |
| Fresh Issue Size | 89,80,600 shares | 8,00,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹61.07 Cr | up to ₹816.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 89,80,600 shares | 8,00,00,000 shares |
| Issue Size Total (Amount) | up to ₹61.07 Cr | up to ₹816.00 Cr |
Alpa Laboratories IPO opens on Jul 12, 2007, while Central Bank of India IPO opens on Jul 24, 2007. The closing date of Alpa Laboratories IPO and Central Bank of India IPO is Jul 17, 2007, and Jul 27, 2007, respectively.
| Alpa Laboratories IPO | Central Bank of India IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 12, 2007 | Jul 24, 2007 |
| Issue Close | Jul 17, 2007 | Jul 27, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 06, 2007 | Aug 21, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Alpa Laboratories IPO P/E ratio is , as compared to Central Bank of India IPO P/E ratio of .
| Alpa Laboratories IPO | Central Bank of India IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 55.94 | 81.2 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹146.61 Cr. | ₹4122.24 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 23.57 | 15.44 |
In the Alpa Laboratories IPO Retail Individual Investors (RII) are offered 32,37,500 shares while in Central Bank of India IPO retail investors are offered 32,37,500 shares. Qualified Institutional Buyers (QIB) are offered 46,25,000 shares in Alpa Laboratories IPO and 4,56,00,000 shares in Central Bank of India IPO.
| Alpa Laboratories IPO | Central Bank of India IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 46,25,000 shares | 4,56,00,000 shares |
| NII | 13,87,500 shares | 76,00,000 shares |
| RII | 32,37,500 shares | 2,28,00,000 shares |
| Employee | 2,50,000 shares | 40,00,000 shares |
| Others | ||
| Total | 95,00,000 shares | 8,00,00,000 shares |
Alpa Laboratories IPO subscribed 1.11x in total, whereas Central Bank of India IPO subscribed 62.07x.
| Alpa Laboratories IPO | Central Bank of India IPO | |
|---|---|---|
| QIB (times) | 0.18x | 89.12x |
| NII (times) | 1.99x | 69.58x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.14x | 16.20x |
| Employee (times) | 0.01x | 0.96x |
| Other (times) | ||
| Total (times) | 1.11x | 62.07x |
